Skip to content
Company Analysis

Qiagen N.V. QGEN

A comprehensive view of key metrics, scores, and financial health for Qiagen N.V.

Overview of Qiagen N.V.

QGEN NYQ
Healthcare Diagnostics & Research Framework: Medical Devices & Diagnostics Mid Cap
Qiagen N.V. (QGEN), is a Mid Cap company, in the Diagnostics & Research industry, last closed at $37.06, about 50.8% overvalued vs fair value, -21.3% 1Y return, placing in the top 10% of its sector.
Metrics P/E 22.0× Rev Growth 5.7% ROE 11.6% Gross Margin 61.8% Div Yield 0.55%
USD 37.06
-0.96%
(Delayed)
• Vol 90d: 34.1%
52-Week Range
Market Cap
$7.66B
Enterprise Value
$8.63B
Overall Score
View breakdown
Overall
Growth
Good
Profitability
Excellent
Health
Fair
Efficiency
Fair
Valuation
Fair
Growth
Good
Profitability
Excellent
Health
Fair
Efficiency
Fair
Valuation
Fair
Completeness: 82%
Confidence: 55%
Updated: Mar 8
Top Beats
No strong beats yet

Quick Facts

Website https://www.qiagen.com
HQ Venlo
Employees 5,700
Fiscal year Dec 31

Next Events

Dividend Jul 14 Ex-div: Jul 7
Earnings Aug 4 Estimated

Fair Value Snapshot

Bear Base Bull
$16
$18
$20
Current: $37.06 -51% vs base

Engine Room Money Flow™

Mid Cap

Medical Devices & Diagnostics - Where revenue goes and how value is created

Flow Steps
Total Revenue
$2.1B
5.7%%
Gross Profit
$1.3B
34.3%%
Operating Income (GAAP)
$520.3M
160.3%%
EBITDA
$717.3M
94.8%%
Money Flow Bridge
Flow Direction: Money moves from left to right
Components: Breakdown shows composition of each stage
Industry-Specific: Medical Devices & Diagnostics

Quality & Reliability Indicators

Gross Margin
62.2%
Good

Gross Profit / Revenue — primary moat signal for MedTech. ≥65% indicates IP-protected consumables with strong pricing power.

Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium

Owner's Pocket - Capital Allocation

Total Returned to Shareholders

Combined dividends, buybacks, and debt reduction

$292.1M
58.2% of Free Cash Flow

Where It Leaks

Cash Flow Health healthy
Strong cash conversion with minimal leakage across profit-to-cash-to-value chain.
0
Active Leaks
0/0
Improving
0
High Impact
0
Critical
Moat Analysis Medical Devices & Diagnostics

Competitive Advantage Assessment

Evaluating Qiagen N.V.'s durable competitive advantages across 6 defense dimensions

Overall Moat Strength
67
/100
Moderate
Scores based on quantitative metrics and qualitative factors

Upgrade to unlock interactive defense details

Premium access

Unlock full defense analysis

Get key signals, strengths, and risks for every moat dimension.

Upgrade to Premium Unlock all moat defenses and evidence.

Pricing Power & Consumable Moat

Moderate
53
Premium
Unlock full defense details

See key signals plus strengths and risks for this moat dimension.

Upgrade for full defense analysis Premium-only evidence and insights.
For informational purposes only. Not investment advice.

Trade-Off Ledger™

Where management spends the performance budget - Growth, Profitability, or Safety

Generic Industrial / Default vs Industry Peers 100% Coverage
Trade-Off Triangle Visualization A ternary plot showing QGEN's balance between Growth (26.1%), Profitability (40.7%), and Safety (33.2%). Growth 26% Safety 33% Profitability 41%

Click axes to expand details. Marker shows current allocation.

3-Year Trend Analysis Locked
Upgrade to unlock the full 3-year trend analysis and deltas.

Growth

53th percentile vs peers
54
Key Signals
EPS Growth YoY 4.07 99p Rev Growth YoY 5.7% 48p EPS CAGR 3Y 0.9% 50p Revenue CAGR 3Y -0.8% 27p TSR 1.6% 49p
Strengths
  • EPS Growth YoY in top 20% of peers (4.07, 99th percentile)
  • Interest Coverage Ratio in top 20% of peers (15.74, 86th percentile)
  • Superior capital returns - 3 return metrics above peer median
Risks

No significant risks identified for this axis.

Profitability

83th percentile vs peers
84
Key Signals
Strengths
Risks
Premium
Unlock full Profitability drilldowns

See the signal-level drivers and insights behind this axis. Upgrade to reveal the full Trade-Off Ledger.

Upgrade Now

Safety

68th percentile vs peers
69
Key Signals
Strengths
Safety drilldowns are available to premium members.

Two Futures

Scenario-based fair value ranges for Qiagen N.V..

Loading valuation model...
Unable to Compute Fair Value

This company cannot be valued using standard models.

What this means: The Scenario Theatre requires financial data (revenue, cash flow, shares outstanding) to calculate fair value estimates. This data may be unavailable for:

  • Recently listed companies (IPOs, SPACs)
  • Shell companies or holding companies
  • Companies that haven't filed recent financials
  • Foreign companies with limited data coverage
X.X%
X%XX%
X.X%
-XX%XX%
XX.X%
-XX%XX%
Adjust the sliders above to explore different valuation scenarios.
Unlock Premium
Reveal the full Scenario Theatre
See live sliders, narratives, and full Bear/Base/Bull outcomes.
Upgrade Now
Bear
-
- - -
- upside
-
Base
$18.22
- - -
-50.8% vs current
Snapshot base estimate
Bull
-
- - -
- upside
-
Fair Value Range Current: $-
$- $- $-
Actions & Info
Send Feedback
Please select a category.
0/1000